TriSalus Life Sciences, Inc. Insider Transactions
TriSalus Life Sciences, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Devlin Jodi
Chief of Clinical Operations |
Sell | 4,764 @ $5.18 | $24.68 K | 52,764 | 05/19/2025 | 05/21/2025 | |
|
Cox Bryan F.
Chief of Research |
Sell | 4,764 @ $5.18 | $24.68 K | 119,415 | 05/19/2025 | 05/21/2025 | |
|
Marshak Richard
Chief Commercial Officer |
Sell | 6,597 @ $5.18 | $34.17 K | 69,101 | 05/19/2025 | 05/21/2025 | |
|
Stevens Jennifer
Chief Regulatory Officer |
Sell | 8,704 @ $5.18 | $45.09 K | 77,640 | 05/19/2025 | 05/21/2025 | |
| Buy | 6,000 @ $5.65 | $33.90 K | 30,000 | 02/05/2025 | 02/06/2025 | ||
|
Szela Mary T
CEO |
Buy | 5,010 @ $5.28 | $26.45 K | 444,259 | 01/30/2025 | 01/31/2025 | |
|
Szela Mary T
CEO |
Buy | 5,030 @ $5.03 | $25.30 K | 439,249 | 01/29/2025 | 01/31/2025 | |
|
Szela Mary T
CEO |
Buy | 4,716 @ $5.12 | $24.15 K | 434,219 | 01/28/2025 | 01/29/2025 | |
|
Murphy Sean
Director, Chief Manuf, Strategy&Bus Dev. |
Buy | 15,000 @ $5.17 | $77.55 K | 197,732 | 01/28/2025 | 01/29/2025 | |
|
Szela Mary T
CEO |
Buy | 4,826 @ $5.42 | $26.16 K | 429,503 | 01/27/2025 | 01/29/2025 | |
|
Murphy Sean
Director, Chief Manuf, Strategy&Bus Dev. |
Buy | 15,000 @ $5.31 | $79.65 K | 182,732 | 01/27/2025 | 01/29/2025 | |
| Buy | 24,000 @ $5.40 | $129.60 K | 24,000 | 01/27/2025 | 01/29/2025 | ||
|
Frankenius Equity AB
10 percent owner |
Buy | 62,972 @ $3.97 | $250.00 K | 6,230,748 | 12/17/2024 | 12/19/2024 | |
|
Desai Arjun JJ
Director |
Sell | 30,000 @ $3.69 | $110.70 K | 247,127 | 12/10/2024 | 12/12/2024 | |
|
Wahlstrom Mats
Director, 10 percent owner: |
Buy | 5,000 @ $4.55 | $22.75 K | 15,727 | 11/22/2024 | 11/25/2024 | |
|
Wahlstrom Mats
Director, 10 percent owner: |
Buy | 8,687 @ $4.44 | $38.57 K | 10,727 | 11/21/2024 | 11/22/2024 | |
|
Wahlstrom Mats
Director, 10 percent owner: |
Buy | 2,040 @ $4.16 | $8.49 K | 2,040 | 11/20/2024 | 11/22/2024 | |
|
Cox Bryan F.
CHIEF SCIENTIFIC & MANUFACT. |
Sell | 314 @ $4.44 | $1.39 K | 86,382 | 10/05/2024 | 12/19/2024 | |
|
Szela Mary T
CEO |
Buy | 6,000 @ $5.00 | $30.00 K | 384,677 | 09/13/2024 | 09/13/2024 | |
|
Szela Mary T
CEO |
Buy | 1,295 @ $4.83 | $6.26 K | 378,677 | 09/13/2024 | 09/13/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TriSalus Life Sciences, Inc. FAQ's
The list of insiders at TriSalus Life Sciences, Inc. includes Frankenius Equity AB, Szela Mary T, Murphy Sean, Young James Emmett, Cox Bryan F., Devlin Jodi, Marshak Richard, Stevens Jennifer.
Insiders have sold a total of 24.83 K TriSalus Life Sciences, Inc. shares in the last 12 months for a total of 128.61 K sold.
The following insiders have sold TriSalus Life Sciences, Inc. shares in the last 12 months: Cox Bryan F. ($24.68 K), Devlin Jodi ($24.68 K), Marshak Richard ($34.17 K), Stevens Jennifer ($45.09 K),
Insiders have purchased a total of 142.55 K TriSalus Life Sciences, Inc. shares in the last 12 months for a total of 672.76 K.
The following insiders have purchased TriSalus Life Sciences, Inc. shares in the last 12 months: Frankenius Equity AB ($250.00 K), Szela Mary T ($102.06 K), Murphy Sean ($157.20 K), Young James Emmett ($163.50 K),